Megakaryocyte-targeted synthesis of the integrin beta(3)-subunit results in the phenotypic correction of Glanzmann thrombasthenia.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Blood

• Publication date

  2000-06-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD.V95.12.3645PMID 10845892
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• An oral CD40 ligand gene therapy against lymphoma using attenuated Salmonella typhimurium.

  2000cited by this paper
• Integrin alphaIIb promoter-targeted expression of gene products in megakaryocytes derived from retrovirus-transduced human hematopoietic cells.

  1999cited by this paper
• Retroviral-mediated gene transfer of the leukocyte integrin CD18 into peripheral blood CD34+ cells derived from a patient with leukocyte adhesion deficiency type 1.

  1998cited by this paper
• Isolation of CD34+ cells from blood stem cell components using the Baxter Isolex system

  1998cited by this paper
• Polymorphism of Platelet Membrane Glycoprotein IIIa: Human Platelet Antigen 1b (HPA-1b/PlA2) Is an Inherited Risk Factor for Premature Myocardial Infarction in Coronary Artery Disease

  1998cited by this paper
• Integrin-mediated Activation of Focal Adhesion Kinase Is Independent of Focal Adhesion Formation or Integrin Activation

  1997cited by this paper
• Truncation of the cytoplasmic domain of beta3 in a variant form of Glanzmann thrombasthenia abrogates signaling through the integrin alpha(IIb)beta3 complex.

  1997cited by this paper
• Thrombopoietin-induced Expression of the Glycoprotein IIb Gene Involves the Transcription Factor PU.1/Spi-1 in UT7-Mpl Cells*

  1997cited by this paper
• A 2.7-kb portion of the 5' flanking region of the murine glycoprotein alphaIIb gene is transcriptionally active in primitive hematopoietic progenitor cells.

  1997cited by this paper
• A genetic analysis of integrin function: Glanzmann thrombasthenia in vitro.

  1997cited by this paper
• Immunization against platelet glycoprotein IIb‐IIIa in Glanzmann's thrombasthenia

  1997cited by this paper
• Hematologically important mutations: Glanzmann thrombasthenia.

  1997cited by this paper
• A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis.

  1996cited by this paper
• Glanzmann thrombasthenia. Cooperation between sequence variants in cis during splice site selection.

  1996cited by this paper
• The tissue-specific transcriptional regulation of the megakaryocytic glycoprotein IIb gene is controlled by interactions between a repressor and positive cis-acting elements.

  1996cited by this paper
• Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells

  1996cited by this paper
• Platelets generated in vitro from proplatelet-displaying human megakaryocytes are functional.

  1995cited by this paper
• Regulation of Gene Transcription During the Differentiation of Megakaryocytes

  1995cited by this paper
• Human Platelet Alloantigens: Recent Findings, New Perspectives

  1995cited by this paper
• Use of Sodium Butyrate to Enhance Production of Retroviral Vectors Expressing CFTR cDNA

  1995cited by this paper
• Suppression of erythro-megakaryocytopoiesis and the induction of reversible thrombocytopenia in mice transgenic for the thymidine kinase gene targeted by the platelet glycoprotein alpha IIb promoter [published erratum appears in J Exp Med 1995 Oct 1;182(4):1177]

  1995cited by this paper
• Transcriptional regulation of alpha IIb integrin gene expression during megakaryocytic differentiation of K562 cells. Role of a silencer element.

  1994cited by this paper
• A New Family of Murine Retroviral Vectors with Extended Multiple Cloning Sites for Gene Insertion

  1994cited by this paper
• Integrin cytoplasmic domains mediate inside-out signal transduction

  1994cited by this paper
• A single amino acid substitution flanking the fourth calcium binding domain of alpha IIb prevents maturation of the alpha IIb beta 3 integrin complex.

  1994cited by this paper
• Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl.

  1994cited by this paper
• Inherited Diseases of Platelet Glycoproteins: Considerations for Rapid Molecular Characterization

  1994cited by this paper
• Characterization of regulatory elements in the 5'-flanking region of the rat GPIIb gene by studies in a primary rat marrow culture system.

  1994cited by this paper
• Retroviral vectors.

  1994cited by this paper
• Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor MpI

  1994cited by this paper
• A 2.|E|-Bit Distributed Algorithm for the Directed Euler Trail Problem

  1993cited by this paper
• The transcription factor GATA-1 regulates the promoter activity of the platelet glycoprotein IIb gene.

  1993cited by this paper
• Characterization of a specific erythromegakaryocytic enhancer within the glycoprotein IIb promoter.

  1992cited by this paper
• Retroviral vectors.

  1992cited by this paper
• Tissue-specific expression of the platelet GPIIb gene.

  1991cited by this paper
• Detection of the Glanzmann's Thrombasthenia Mutations in Arab and Iraqi-Jewish Patients by Polymerase Chain Reaction and Restriction Analysis of Blood or Urine Samples

  1991cited by this paper
• Production and characterization of functional domains of human fibronectin expressed in Escherichia coli.

  1991cited by this paper
• Effect of single amino acid substitutions on the formation of the PlA and Bak alloantigenic epitopes.

  1991cited by this paper
• Regulation of adhesion of ICAM-1 by the cytoplasmic domain of LFA-1 integrin beta subunit.

  1991cited by this paper
• Affinity modulation of the alpha IIb beta 3 integrin (platelet GPIIb-IIIa) is an intrinsic property of the receptor.

  1990cited by this paper
• Organization of the gene for platelet glycoprotein IIb.

  1990cited by this paper
• Megakaryocytic and erythrocytic lineages share specific transcription factors

  1990cited by this paper
• Glanzmann's thrombasthenia: the spectrum of clinical disease.

  1990cited by this paper
• Processing and assembly of the integrin, glycoprotein IIb-IIIa, in HEL cells.

  1989cited by this paper
• Biosynthesis and assembly of platelet GPIIb-IIIa in human megakaryocytes: evidence that assembly between pro-GPIIb and GPIIIa is a prerequisite for expression of the complex on the cell surface.

  1989cited by this paper
• Expression of recombinant platelet glycoprotein IIbIIIa results in a functional fibrinogen-binding complex.

  1989cited by this paper
• Partial characterization of a binding site for von Willebrand factor on glycocalicin.

  1986cited by this paper
• Quantitation of membrane glycoprotein IIIa on intact human platelets using the monoclonal antibody, AP-3.

  1985cited by this paper
• A Glanzmann’s Thrombasthenia Cluster Among Iraqi Jews in Israel

  1984cited by this paper
• Interaction of AP-2, a monoclonal antibody specific for the human platelet glycoprotein IIb-IIIa complex, with intact platelets.

  1983cited by this paper
• Heterogeneity of membrane surface proteins in Glanzmann's thrombasthenia.

  1981cited by this paper
• Platelets Generated in Vitro from Proplatelet-displaying Human Megakaryocytes Are Functional Isolation of Cd34+ Progenitor Cells from Peripheral Blood

  year unknowncited by this paper

• A single F153Sβ3 mutation causes constitutive integrin αIIbβ3 activation in a variant form of Glanzmann thrombasthenia

  2023cites this paper
• Itgb3-integrin-deficient mice may not be a sufficient model for patients with Glanzmann thrombasthenia

  2021cites this paper
• Optimized outcome of pregnancy in a woman with Glanzmann thrombasthenia with multidisciplinary approach

  2021cites this paper
• Bleeding Disorders Associated with Abnormal Platelets: Glanzmann Thrombasthenia and Bernard-Soulier Syndrome

  2020cites this paper
• Glanzmann thrombasthenia: genetic basis and clinical correlates

  2020cites this paper
• Gene Therapy for Platelet Disorders

  2019cites this paper
• Foreword: A Brief History of Ideas About Platelets in Health and Disease

  2019cites this paper
• Acquired Antibodies to αIIbβ3 in Glanzmann Thrombasthenia: From Transfusion and Pregnancy to Bone Marrow Transplants and Beyond.

  2018cites this paper
• Glanzmann thrombasthenia: an editorial perspective

  2018cites this paper
• Advances of blood cell‐based drug delivery systems

  2017cites this paper
• All in the Family: Primary Megakaryocytes for Studies of Platelet <font face="symbol">a</font>IIb<font face="symbol">b</font>3 Signaling

  2017cites this paper
• Strategies for the Gene Modification of Megakaryopoiesis and Platelets

  2016cites this paper
• Megakaryocyte- and megakaryocyte precursor-related gene therapies.

  2016influential citation
• [Current state and prospect in treatment of Glanzmann' s thrombasthenia].

  2016cites this paper
• New Insights Into the Treatment of Glanzmann Thrombasthenia.

  2016cites this paper
• Functional Comparison of Induced Pluripotent Stem Cell- and Blood-Derived GPIIbIIIa Deficient Platelets

  2015cites this paper
• Utilising the zebrafish model organism to study the effect of FLCN in early embryonic development and Genotyping and platelet phenotyping of cases of rare inherited platelet based bleeding disorders

  2013cites this paper
• Platelet-targeted gene therapy with human factor VIII establishes haemostasis in dogs with haemophilia A

  2013cites this paper
• Glanzmann Thrombasthenia: State of the Art and Future Directions

  2013cites this paper
• A Brief History of Ideas About Platelets in Health and Disease

  2013cites this paper
• Model systems of genetically modified platelets.

  2012cites this paper
• Platelet gene therapy improves hemostatic function for integrin αIIbβ3-deficient dogs

  2011cites this paper
• Platelet Functional Genomics

  2011cites this paper
• Gene therapy of canine leukocyte adhesion deficiency using lentiviral vectors with human CD11b and CD18 promoters driving canine CD18 expression.

  2011cites this paper
• Modern management of severe platelet function disorders

  2010cites this paper
• Platelets as delivery systems for disease treatments.

  2010cites this paper
• Correction of murine Bernard-Soulier syndrome by lentivirus-mediated gene therapy.

  2010cites this paper
• Understanding and Improving Platelet-Delivered Factor (F) VIII Hemostatic Efficacy in Hemophilia A Mice

  2010cites this paper
• Potential large animal models for gene therapy of human genetic diseases of immune and blood cell systems.

  2009cites this paper
• Glanzmann’s thrombasthenia (GT) is an autosomal recessive inherited platelet function defect that characterized by reduction in, or absence of, platelet aggregation in response to multiple physiologic agonists. GT is characterized by normal platelet count, prolonged bleeding time, and abnormal clot

  2008cites this paper
• CHAPTER 71 – Gene Therapy for Platelet Disorders

  2007cites this paper
• Lentivirus‐mediated platelet‐derived factor VIII gene therapy in murine haemophilia A

  2007cites this paper
• Platelet-Directed Gene Therapy

  2007cites this paper
• Silencing of a Targeted Protein in In Vivo Platelets Using a Lentiviral Vector Delivering Short Hairpin RNA Sequence

  2007cites this paper
• Methods for genetic modification of megakaryocytes and platelets

  2007cites this paper
• Efficient expression of a transgene in platelets using simian immunodeficiency virus‐based vector harboring glycoprotein Ibα promoter: in vivo model for platelet‐targeting gene therapy

  2006cites this paper
• Therapeutic expression of the platelet-specific integrin, αIIbβ3, in a murine model for Glanzmann thrombasthenia

  2005cites this paper
• Retroviral Infection and Selection of Culture-Derived Platelets Allows Study of the Effect of Transgenes on Platelet Physiology Ex Vivo and on Thrombus Formation In Vivo

  2005cites this paper
• Therapeutic expression of the platelet-specific integrin, alphaIIbbeta3, in a murine model for Glanzmann thrombasthenia.

  2005cites this paper
• Generation of Functional Culture–Derived Platelets From CD34+ Progenitor Cells to Study Transgenes in the Platelet Environment

  2004cites this paper
• Targeting platelet GPIbα transgene expression to human megakaryocytes and forming a complete complex with endogenous GPIbβ and GPIX

  2004cites this paper
• Generation of Functional Culture–Derived Platelets From CD34+ Progenitor Cells to Study Transgenes in the Platelet Environment

  2004cites this paper
• Targeting platelet GPIbalpha transgene expression to human megakaryocytes and forming a complete complex with endogenous GPIbbeta and GPIX.

  2004cites this paper
• Using retroviruses to express genes in primary megakaryocyte lineage cells.

  2004cites this paper
• Meeting Challenges Toward the Gene Therapy Reality in the 21st Century

  2004cites this paper
• Gene therapy for platelet disorders: studies with Glanzmann's thrombasthenia

  2003cites this paper
• Induction of megakaryocytes to synthesize and store a releasable pool of human factor VIII

  2003cites this paper
• Relationships between Rap1b, affinity modulation of integrin alpha IIbbeta 3, and the actin cytoskeleton.

  2002cites this paper
• Two New β3 Integrin Mutations in Indian Patients with Glanzmann Thrombasthenia: Localization of Mutations Affecting Cysteine Residues in Integrin β3

  2002cites this paper
• Genetic Abnormalities of Bernard-Soulier Syndrome

  2002cites this paper
• Expression of Coagulation Factor IX in a Haematopoietic Cell Line

  2002cites this paper
• Adult bone marrow stem cells for cell and gene therapies: Implications for greater use

  2002cites this paper
• Relationships between Rap1b, Affinity Modulation of Integrin αIIbβ3, and the Actin Cytoskeleton*

  2002cites this paper
• Thrombus Formation with Rehydrated, Lyophilized Platelets

  2002cites this paper
• Two new beta3 integrin mutations in Indian patients with Glanzmann thrombasthenia: localization of mutations affecting cysteine residues in integrin beta3.

  2002cites this paper
• All in the Family: Primary Megakaryocytes for Studies of Platelet αIIbβ3 Signaling

  2001cites this paper
• Inherited defects of platelet function.

  2001cites this paper
• Chimera formation of platelet GP II b Bak a/b by intrauterine transplantation of fetal liver stem cells.

  2001cites this paper
• Adenovirus-mediated Expression and Packaging of Tissue-type Plasminogen Activator in Megakaryocytic Cells

  2001cites this paper
• Mechanisms of activation of the leukocyte integrin LFA-1

  2000cites this paper